Novel surface targets and serum biomarkers from the ovarian cancer vasculature
about
Ultrasound molecular imaging in a human CD276 expression-modulated murine ovarian cancer model.FAM83H is involved in the progression of hepatocellular carcinoma and is regulated by MYC.T cells bearing a chimeric antigen receptor against prostate-specific membrane antigen mediate vascular disruption and result in tumor regression.Identification of novel vascular targets in lung cancer.Expression of death receptor 6 by ovarian tumors in laying hens, a preclinical model of spontaneous ovarian cancer.Death receptor 6 (DR6) is required for mouse B16 tumor angiogenesis via the NF-κB, P38 MAPK and STAT3 pathways.A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer.Association of Immunosuppression with DR6 Expression during the Development and Progression of Spontaneous Ovarian Cancer in Laying Hen ModelTumor endothelial marker 1-specific DNA vaccination targets tumor vasculature.Identification and validation of differentially expressed proteins in epithelial ovarian cancers using quantitative proteomics.ADAM12 is a prognostic factor associated with an aggressive molecular subtype of high-grade serous ovarian carcinoma.Vascular marker expression during the development of various types of gynaecological malignancy.Identification of a Peptide from In vivo Bacteriophage Display with Homology to EGFL6: A Candidate Tumor Vasculature Ligand in Breast Cancer.ADAM12 Is a Novel Regulator of Tumor Angiogenesis via STAT3 Signaling.Death receptor 6 promotes ovarian cancer cell migration through KIF11
P2860
Q30417587-E14B979F-AEA4-4923-8AA8-5D1A65B6DD04Q33789691-7A91CFDC-025B-4F0D-9E62-AE5DA879517AQ34893030-0B17B3CF-3D74-434A-B0C3-022C73C4FD4EQ35677838-46F8356A-5E76-4F5F-BC19-AB4AD717381BQ36199847-3DE10DF7-427B-4784-B138-185FB25AA78CQ36748713-BE962B09-A3A7-4C9B-9EC4-1B44AC00BDB7Q36958112-5CBFBE5E-356B-4C07-BF15-2250FE074D12Q37184585-2789D9E9-BD39-4674-9747-017068C8924BQ37679962-F4BA3400-84F8-4F08-9326-DA2DD0F3FC33Q37696286-7FADE106-5917-4405-AC79-B92E27A446BFQ38880697-78E58308-1A51-41E1-B617-735AE90BE71BQ40214132-87B9103C-C546-4518-AC53-EFB3FA9E3FD4Q40867070-0DC9031E-46BC-4098-B105-84E0BAB8D3B6Q48002665-EA5725B6-C27E-49FA-8A1D-960A4CCFD3F8Q58796822-F6450BDB-A743-4AE1-B1CA-F4DCAE5BC8D4
P2860
Novel surface targets and serum biomarkers from the ovarian cancer vasculature
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Novel surface targets and serum biomarkers from the ovarian cancer vasculature
@ast
Novel surface targets and serum biomarkers from the ovarian cancer vasculature
@en
Novel surface targets and serum biomarkers from the ovarian cancer vasculature
@nl
type
label
Novel surface targets and serum biomarkers from the ovarian cancer vasculature
@ast
Novel surface targets and serum biomarkers from the ovarian cancer vasculature
@en
Novel surface targets and serum biomarkers from the ovarian cancer vasculature
@nl
prefLabel
Novel surface targets and serum biomarkers from the ovarian cancer vasculature
@ast
Novel surface targets and serum biomarkers from the ovarian cancer vasculature
@en
Novel surface targets and serum biomarkers from the ovarian cancer vasculature
@nl
P2093
P2860
P3181
P356
P1476
Novel surface targets and serum biomarkers from the ovarian cancer vasculature
@en
P2093
Andrew K Godwin
Dimitra Sasaroli
Dionyssios Katsaros
Eleni Kougioumtzidou
George Coukos
Harsh B Pathak
Karthik Devarajan
Nathalie Scholler
Phyllis A Gimotty
Rachel Hammond
P2860
P304
P3181
P356
10.4161/CBT.12.3.16260
P407
P577
2011-08-01T00:00:00Z